Chinese herbal medicine may improve outcomes after STEMI
Por um escritor misterioso
Descrição
CHICAGO — A drug derived from traditional Chinese medicine as an adjunct to guideline-directed therapy improved CV outcomes at 30 days and 1 year compared with placebo after revascularization, with no excess bleeding risk, a speaker reported.“Despite reperfusion and optimal medical therapy, patients with STEMI still face a high risk of in-hospital mortality, myocardial no-flow and
Machine learning enhances the performance of short and long-term mortality prediction model in non-ST-segment elevation myocardial infarction
Comparison of the modified Singapore myocardial infarction registry risk score with GRACE 2.0 in predicting 1-year acute myocardial infarction outcomes
:max_bytes(150000):strip_icc()/what-are-adaptogens-4685073-primary-recirc-f5ef8698bc704b96ba54710b64fd7a0f.jpg)
Adaptogens: Types and Health Benefits
PDF) Chinese Herbal Medicines Might Improve the Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: Results of a Decision-Analytic Markov Model
Frontiers The known, unknown, and the intriguing about members of a critically endangered traditional medicinal plant genus Aconitum
Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI
Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China
Long-term cardiovascular outcomes of COVID-19
Chinese Herbal Medicine May Offer Benefits in STEMI: CTS-AMI
Chinese Medicine Improves Outcomes in STEMI Patients
Potential traditional Chinese medicines with anti-inflammation in the prevention of heart failure following myocardial infarction, Chinese Medicine
de
por adulto (o preço varia de acordo com o tamanho do grupo)
